HAEM5:B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features: Difference between revisions
| [pending revision] | [pending revision] |
Mark.Evans (talk | contribs) |
Mark.Evans (talk | contribs) |
||
| Line 12: | Line 12: | ||
==Primary Author(s)*== | ==Primary Author(s)*== | ||
Mark G. Evans, MD, Caris Life Sciences | Mark G. Evans, MD, Caris Life Sciences | ||
Sumire K. Kitahara, MD, Cedars-Sinai Medical Center | Sumire K. Kitahara, MD, Cedars-Sinai Medical Center | ||